Susquehanna International Group’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.1M | Buy |
67,050
+12,910
| +24% | +$2.12M | ﹤0.01% | 2955 |
|
|
2025
Q4 | $8.63M | Buy |
54,140
+16,358
| +43% | +$2.25M | ﹤0.01% | 3250 |
|
|
2025
Q3 | $3.54M | Sell |
37,782
-31,248
| -45% | -$2.21M | ﹤0.01% | 4668 |
|
|
2025
Q2 | $3.93M | Buy |
+69,030
| New | +$3.66M | ﹤0.01% | 4426 |
|
|
2025
Q1 | – | Sell |
-60,858
| Closed | -$5.19M | – | 13026 |
|
|
2024
Q4 | $5.48M | Buy |
60,858
+56,585
| +1,324% | +$6.66M | ﹤0.01% | 3454 |
|
|
2024
Q3 | $550K | Buy |
+4,273
| New | +$558K | ﹤0.01% | 8232 |
|
|
2024
Q1 | – | Sell |
-15,077
| Closed | -$1.97M | – | 12802 |
|
|
2023
Q4 | $1.84M | Buy |
+15,077
| New | +$1.15M | ﹤0.01% | 5546 |
|
|
2023
Q1 | – | Sell |
-26,551
| Closed | -$3.6M | – | 13081 |
|
|
2022
Q4 | $3.75M | Buy |
+26,551
| New | +$3.7M | ﹤0.01% | 3669 |
|
|
2022
Q3 | – | Sell |
-929
| Closed | -$170K | – | 13707 |
|
|
2022
Q2 | $125K | Sell |
929
-3,514
| -79% | -$599K | ﹤0.01% | 11239 |
|
|
2022
Q1 | $1.39M | Sell |
4,443
-978
| -18% | -$369K | ﹤0.01% | 6325 |
|
|
2021
Q4 | $3.9M | Buy |
+5,421
| New | +$5.19M | ﹤0.01% | 4173 |
|
|
2021
Q3 | – | Sell |
-4,394
| Closed | -$5.4M | – | 13190 |
|
|
2021
Q2 | $6.47M | Buy |
4,394
+3,857
| +718% | +$5.35M | ﹤0.01% | 3568 |
|
|
2021
Q1 | $848K | Sell |
537
-1,417
| -73% | -$3.32M | ﹤0.01% | 8154 |
|
|
2020
Q4 | $3.92M | Buy |
1,954
+1,667
| +581% | +$2.66M | ﹤0.01% | 3849 |
|
|
2020
Q3 | $308K | Sell |
287
-1,758
| -86% | -$2.02M | ﹤0.01% | 8654 |
|
|
2020
Q2 | $2.43M | Sell |
2,045
-471
| -19% | -$408K | ﹤0.01% | 4147 |
|
|
2020
Q1 | $1.13M | Sell |
2,516
-3,057
| -55% | -$2.78M | ﹤0.01% | 5114 |
|
|
2019
Q4 | $6.41M | Buy |
+5,573
| New | +$5M | ﹤0.01% | 2635 |
|
|
2019
Q3 | – | Sell |
-3,066
| Closed | -$2.55M | – | 10532 |
|
|
2019
Q2 | $3.08M | Sell |
3,066
-865
| -22% | -$838K | ﹤0.01% | 3406 |
|
|
2019
Q1 | $4.71M | Sell |
3,931
-6,185
| -61% | -$6.43M | ﹤0.01% | 2526 |
|
|
2018
Q4 | $6.65M | Buy |
10,116
+8,841
| +693% | +$9.27M | ﹤0.01% | 1980 |
|
|
2018
Q3 | $2.37M | Buy |
1,275
+710
| +126% | +$1.39M | ﹤0.01% | 3725 |
|
|
2018
Q2 | $1.07M | Sell |
565
-1,260
| -69% | -$2.22M | ﹤0.01% | 5188 |
|
|
2018
Q1 | $2.9M | Buy |
+1,825
| New | +$3.4M | ﹤0.01% | 3310 |
|
|
2017
Q4 | – | Sell |
-430
| Closed | -$658K | – | 9605 |
|
|
2017
Q3 | $735K | Sell |
430
-720
| -63% | -$999K | ﹤0.01% | 5843 |
|
|
2017
Q2 | $1.45M | Buy |
1,150
+869
| +309% | +$877K | ﹤0.01% | 4502 |
|
|
2017
Q1 | $269K | Buy |
+281
| New | +$250K | ﹤0.01% | 7517 |
|
|
2016
Q3 | – | Sell |
-2,192
| Closed | -$1.81M | – | 8745 |
|
|
2016
Q2 | $1.24M | Sell |
2,192
-984
| -31% | -$616K | ﹤0.01% | 4421 |
|
|
2016
Q1 | $1.74M | Buy |
+3,176
| New | +$2.01M | ﹤0.01% | 4036 |
|
|
2015
Q4 | – | Sell |
-150
| Closed | -$243K | – | 9702 |
|
|
2015
Q3 | $195K | Sell |
150
-8
| -5% | -$24.4K | ﹤0.01% | 8728 |
|
|
2015
Q2 | $604K | Buy |
+158
| New | +$560K | ﹤0.01% | 7251 |
|
Other funds holding LABU
JF
TRCT
XT
HF
MIG
TSS
AF
Susquehanna International Group's LABU Position: Q1 2026 in Review
Susquehanna International Group increased its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 24% in Q1 2026, buying an estimated $2.12M and bringing the position to 67,050 shares worth $11.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2955.
Susquehanna International Group first reported a position in LABU in Q2 2015 and has held it in 31 quarters since. 33 funds tracked by Wall St. Rank hold LABU as of Q1 2026.
- Susquehanna International Group held 67,050 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $11.1M as of Q1 2026.
- Susquehanna International Group bought 12,910 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2026, an estimated $2.12M.
- Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2955 holding.
- Susquehanna International Group first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2015 and has held it in 31 quarters since.
- 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.